Young, Alexandra L. http://orcid.org/0000-0002-7772-781X
Oxtoby, Neil P. http://orcid.org/0000-0003-0203-3909
Garbarino, Sara http://orcid.org/0000-0002-3583-3630
Fox, Nick C.
Barkhof, Frederik http://orcid.org/0000-0003-3543-3706
Schott, Jonathan M.
Alexander, Daniel C. http://orcid.org/0000-0003-2439-350X
Article History
Accepted: 30 November 2023
First Online: 8 January 2024
Competing interests
: N.P.O. consults for TheraPanacea (FR) and Queen Square Analytics (UK). F.B. and D.C.A. hold an equity stake in Queen Square Analytics (UK). F.B. is a steering committee or Data Safety Monitoring Board member for Biogen, Merck, ATRI/ACTC and Prothena; a consultant for Roche, Celltrion, Rewind Therapeutics, Merck, IXICO, Jansen and Combinostics; and has research agreements with Merck, Biogen, GE Healthcare and Roche. The other authors declare no competing interests.